Subscribe
23 August 2018Big Pharma

Novo Nordisk and Evotec partner to develop diabetes drugs

Danish healthcare company Novo Nordisk has entered into an alliance with Germany-based Evotec to develop treatments for diabetes and obesity.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Novo Nordisk pays $800m for start-up’s diabetes tech platform
20 August 2018   Novo Nordisk has bought a University of Bristol spin-out company for $800 million, in a deal which could transform the way diabetes is treated.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
Novo Nordisk pays $800m for start-up’s diabetes tech platform
20 August 2018   Novo Nordisk has bought a University of Bristol spin-out company for $800 million, in a deal which could transform the way diabetes is treated.

More on this story

Big Pharma
Novo Nordisk pays $800m for start-up’s diabetes tech platform
20 August 2018   Novo Nordisk has bought a University of Bristol spin-out company for $800 million, in a deal which could transform the way diabetes is treated.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility